Contrary to the hypothesis that those upregulated candidate genes might be a survival benefit for ovarian cancer, high IGFBP4 and TGFBI gene expressions were associated with decreased OS rather than prolonged survival (Figure 3). This evidence concerns the gene TGFBI and ovarian carcinoma.